Hanall Biopharma (009420) — Net Asset Momentum
Hanall Biopharma (009420) recorded a net asset momentum of -9.6% as of December 2024, with net assets of ₩168.35 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Hanall Biopharma (009420) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hanall Biopharma Net Asset Momentum (2011–2024)
This chart tracks Hanall Biopharma's year-over-year net asset growth across 14 annual reporting periods from 2011 to 2024. The most recent momentum reading is -9.6%, with net assets of ₩168.35 Billion KRW as of December 2024. Read 009420 total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hanall Biopharma (2011–2024)
The table below shows the complete annual net asset history for Hanall Biopharma from 2011 to 2024, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 009420 stock market capitalisation.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩168.35 Billion | ₩212.88 Billion | ₩44.53 Billion | ▼ -9.6% |
| 2023 | ₩186.22 Billion | ₩239.75 Billion | ₩53.53 Billion | ▲ +10.7% |
| 2022 | ₩168.26 Billion | ₩213.45 Billion | ₩45.19 Billion | ▲ +2.9% |
| 2021 | ₩163.49 Billion | ₩198.48 Billion | ₩34.99 Billion | ▼ -9.8% |
| 2020 | ₩181.27 Billion | ₩220.13 Billion | ₩38.86 Billion | ▲ +29.1% |
| 2019 | ₩140.42 Billion | ₩191.38 Billion | ₩50.97 Billion | ▲ +20.1% |
| 2018 | ₩116.92 Billion | ₩162.30 Billion | ₩45.39 Billion | ▲ +5.1% |
| 2017 | ₩111.20 Billion | ₩168.70 Billion | ₩57.50 Billion | ▲ +6.6% |
| 2016 | ₩104.36 Billion | ₩124.73 Billion | ₩20.37 Billion | ▲ +9.6% |
| 2015 | ₩95.22 Billion | ₩117.13 Billion | ₩21.91 Billion | ▲ +107.9% |
| 2014 | ₩45.81 Billion | ₩87.17 Billion | ₩41.36 Billion | ▼ -23.2% |
| 2013 | ₩59.63 Billion | ₩97.85 Billion | ₩38.23 Billion | ▼ -24.2% |
| 2012 | ₩78.67 Billion | ₩124.27 Billion | ₩45.60 Billion | ▲ +55.2% |
| 2011 | ₩50.70 Billion | ₩105.46 Billion | ₩54.75 Billion | — |